Critical Lab Criteria
Cord Blood and Cord Tissue Processing Delays
Any delay in processing of your baby's cord blood and cord tissue can result in a significant loss of viable stem cells. If the lab only processes specimens on weekdays or between limited hours, your baby's cord blood and cord tissue could be left unattended and unprocessed for many hours or even days, leaving it vulnerable to massive stem cell loss.
MiracleCord has the unique ability to process your baby's cord blood and cord tissue within 12 hours of collection.1
1 MiracleCord has the ability to process cord blood specimens within 12 hours of collection, subject to certain conditions beyond MiracleCord's control.
Stem Cell Expansion
Prior to being transplanted, mesenchymal stem cells (MSCs) must be isolated and expanded to maximize their treatment potential. Many cord blood and cord tissue banks do not have the ability to complete this very critical step. Instead, when their clients need a stem cell transplant, they are placed in the difficult position of trying to locate an alternate laboratory on their own, which could potentially cause irreparable delays.
MiracleCord's lab has the technical expertise and the operating facility required for complete MSC expansion, without outsourcing to any other lab.
The AABB is a key international association of blood banks that establishes the standards of care in all aspects of blood banking and tissue transplantation. The AABB works closely with the FDA to provide technical guidance for the development of blood regulations. AABB accreditation ensures that the lab adheres to the most stringent guidelines for processing and storing cord blood.
Labs unable to meet the AABB's guidelines may seek accreditation from one of several obscure accrediting bodies. Guidelines for governing other accrediting organizations have not been standardized within the industry.
MiracleCord's lab is AABB accredited and is in good standing.
Some cord blood banks will forego critical testing procedures that may limit your family's ability to use your baby's stem cells in the future. The AABB and FDA require several clinical tests to be performed on cord blood stem cells at the time of initial processing. Without these tests, the FDA may restrict your baby's stem cells from being released and used for transplant.
MiracleCord performs all required testing during initial processing to ensure compliance with AABB standards and FDA guidelines.